Skip to main content
PharmaTher Holdings Ltd. logo

PharmaTher Holdings Ltd. — Investor Relations & Filings

Ticker · PHRM ISIN · CA71716H1082 LEI · 529900PIPSZ1ZSWF3A21 CSE Manufacturing
Open in API
Filings indexed 279 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country CA Canada
Listing CSE PHRM

About PharmaTher Holdings Ltd.

https://www.pharmather.com/

PharmaTher Holdings Ltd. is a specialty pharmaceutical company dedicated to the research, development, and commercialization of novel therapeutics, primarily focusing on ketamine and psychedelic compounds. The company's strategy involves advancing three core assets: the KETARX™ portfolio of ketamine drugs, which targets neuropsychiatric and pain disorders; the proprietary PharmaPatch™ microneedle patch platform, designed for the transdermal delivery of ketamine, psychedelics, and GLP-1 drugs; and a 49% ownership interest in Sairiyo Therapeutics Inc., which is developing a patented oral formulation of cepharanthine for infectious diseases and cancer. PharmaTher is focused on achieving regulatory approval for its pipeline candidates to address significant global unmet medical needs in mental health, neurological, and pain disorders.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-05-13 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2026-04-29 English
Interim MD&A - English.pdf
Regulatory Filings
2026-04-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2026-04-29 English
News release - English.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release distributed via Newsfile Corp announcing the company’s view on a recent U.S. executive order and its strategic implications. It does not present financial results, management changes, or formal regulatory filings, nor is it a report itself (e.g., 10-K or interim report). It is a general business update that does not fit any specific category, so it falls under the fallback category for miscellaneous regulatory/general announcements (RNS).
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from PharmaTher Holdings Ltd. discussing regulatory developments and commercial opportunities related to their microneedle patch platforms in the psychedelics and peptides markets. It contains no financial statements, no detailed financial performance data, no management discussion of financial results, and no regulatory filings or certifications. It is a corporate announcement focused on business strategy, product platforms, and market opportunities rather than a formal financial or regulatory report. The document length is about 10,892 characters, which is substantial but the content is clearly a business update or corporate news release. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is not a presentation or call transcript either. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement or corporate news release that does not fit other specific categories.
2026-04-20 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.